← Leaderboards
M Carrie Miceli
University Of California Los Angeles
$7,403,834
Attributed
$8,938,231
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,938,231 · 8
By mechanism
R01$4,472,824 · 3
P30$1,728,446 · 2
T32$1,308,336 · 1
RC1$995,500 · 1
R21$433,125 · 1
Top collaborators
- Rachelle Hope Crosbie5 shared
- Feng Guo2 shared
- Stanley F. Nelson2 shared
- Melissa Jan Spencer2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Rachelle Hope Crosbie$11,515,062
- Antoni Ribas$28,929,216
- Dorthe Schaue$6,372,771
- Kenneth Allan Dorshkind$13,544,292
- Christopher Seet$1,554,283
Others in their field
Top investigators on “Muscle Cells”
- Kenton M Sanders · University Of Nevada Reno$53,490,477
- Gary K Owens · University Of Virginia$34,050,563
- Thomas None Quertermous · Stanford University$33,600,700
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$33,515,441
- Stephen J. Tapscott · Fred Hutchinson Cancer Center$28,393,172
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$28,266,443
Research focus
Muscle CellsCellsDesignBaseMuscular DystrophiesMolecularMuscleHigh Throughput ScreeningResourcesMyopathyCellular BiologyResearch PersonnelLeadSmall Interfering RnaImageClinical TrialsMuscle FibersClinicInvestmentsDrug DiscoveryAdoptionMemberCell ModelCdna Library
Grant awards (34)
Structure-based antisense therapeutics targeting dystrophin exons 44 and 45 for Duchenne Muscular Dystrophy$196,875
R21 · FY2025 · HD
Structure-based antisense therapeutics targeting dystrophin exons 44 and 45 for Duchenne Muscular Dystrophy$236,250
R21 · FY2024 · HD
Muscle Cell Biology, Pathophysiology, and Therapeutics$305,875
T32 · FY2020 · AR
Muscle Cell Biology, Pathophysiology, and Therapeutics$310,488
T32 · FY2019 · AR
Muscle Cell Biology, Pathophysiology, and Therapeutics$309,109
T32 · FY2018 · AR
Highthroughput Screening and Cell Repository$100,100
P30 · FY2018 · AR · contact PI
Highthroughput Screening and Cell Repository$205,333
P30 · FY2017 · AR · contact PI
Muscle Cell Biology, Pathophysiology, and Therapeutics$192,741
T32 · FY2017 · AR
Highthroughput Screening and Cell Repository$205,333
P30 · FY2016 · AR · contact PI
Muscle Cell Biology, Pathophysiology, and Therapeutics$190,123
T32 · FY2016 · AR
Highthroughput Screening and Cell Repository$205,335
P30 · FY2015 · AR · contact PI
Highthroughput Screening and Cell Repository$205,335
P30 · FY2014 · AR · contact PI
Highthroughput Screening Core$189,862
P30 · FY2013 · AR · contact PI
Highthroughput Screening Core$177,518
P30 · FY2012 · AR · contact PI
Highthroughput Screening Core$177,517
P30 · FY2011 · AR · contact PI
Identification of Enhancers of Therapeutic Exon Skipping for DMD$497,653
RC1 · FY2010 · AR · contact PI
Highthroughput Screening Core$119,788
P30 · FY2010 · AR · contact PI
Identification of Enhancers of Therapeutic Exon Skipping for DMD$497,847
RC1 · FY2009 · AR · contact PI
Coreceptor Modification of TCR Tyrosine Kinase Signals$381,045
R01 · FY2009 · AI · contact PI
Highthroughput Screening Core$142,325
P30 · FY2009 · AR · contact PI
Coreceptor Modification of TCR Tyrosine Kinase Signals$323,350
R01 · FY2008 · AI · contact PI
Coreceptor Modification of TCR Tyrosine Kinase Signals$43,968
R01 · FY2008 · AI · contact PI
Galectin-1 regulation of T cell activation and tolerance$361,494
R01 · FY2007 · AI · contact PI
Coreceptor Modification of TCR Tyrosine Kinase Signals$329,612
R01 · FY2007 · AI · contact PI
Galectin-1 regulation of T cell activation and tolerance$372,291
R01 · FY2006 · AI · contact PI
Coreceptor Modification of TCR Tyrosine Kinase Signals$339,457
R01 · FY2006 · AI · contact PI
Galectin-1 regulation of T cell activation and tolerance$381,250
R01 · FY2005 · AI
Coreceptor Modification of TCR Tyrosine Kinase Signals$295,481
R01 · FY2005 · AI
Galectin-1 regulation of T cell activation and tolerance$381,250
R01 · FY2004 · AI
CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS$278,313
R01 · FY2003 · CA
Galectin-1 regulation of T cell activation and tolerance$190,625
R01 · FY2003 · AI
CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS$278,313
R01 · FY2002 · CA
CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS$240,975
R01 · FY2001 · CA
CORECEPTOR MODIFICATION OF TCR TYROSINE KINASE SIGNALS$275,400
R01 · FY2000 · CA